Skip to main content

Select Drug Profiles

Lung Cancer, Oncology

Shifts in Lung Cancer Treatment

Edward Garon, MD

Lung Cancer, Oncology

A Look at PD-1 and PD-L1 Inhibitors

Edward Garon, MD

Lung Cancer, Oncology

ALK Gene Rearrangement and PD-L1 Expression

Edward Garon, MD

Lung Cancer, Oncology

Differences in NSCLC Patient Populations

Edward Garon, MD

Lung Cancer, Oncology

Choosing the Right Therapy for Patients with NSCLC

Edward Garon, MD

Lung Cancer, Oncology

Immunotherapies and Lung Cancer

Edward Garon, MD

Lung Cancer, Oncology

My Practice: Roles and Responsibilities

Edward Garon, MD

Lung Cancer, Oncology

Challenges in Managing Toxicities

Edward Garon, MD

Original Research

Comparing Healthcare Utilization and Costs Among Medicaid-Insured Patients with Chronic Noncancer Pain with and without Opioid-Induced Constipation: A Retrospective Analysis

Tope Olufade, PhD, MPH, Amanda M. Kong, MPH, Nicole Princic, MS, Paul Juneau, MS, Rucha Kulkarni, MPH, Kui Zhang, MD, Catherine Datto, MD, MS

Tope Olufade, PhD, MPH; Amanda M. Kong, MPH; Nicole Princic, MS; Paul Juneau, MS; Rucha Kulkarni, MPH; Kui Zhang, MD; Catherine Datto, MD, MS

Stakeholder Perspective

The Opioid Epidemic: Healthcare Utilization and Cost Considerations

Jack E. Fincham, PhD, RPh

by Jack E. Fincham, PhD, RPh

Conference Correspondent, Conference Highlights AMCP

Payers’ Perspective: Incorporating Real-World Evidence in Patient Care

Lilly Ostrovsky

Lilly Ostrovsky

Page 92 of 244
Results 911 - 920 of 2434